Home › Funds › Dauntless Investment Group, LLC › KZIA
Dauntless Investment Group, LLC position in KZIA
KAZIA THERAPEUTICS LTD · Health Care
Dauntless Investment Group, LLC reported holding 866,223 shares of KZIA (KAZIA THERAPEUTICS LTD) in its Q3 2026 13F filing — a position valued at US$8.3M, representing 8.44% of its reported portfolio and ranking #4 among its reported holdings. Dauntless Investment Group, LLC has disclosed KZIA holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Dauntless Investment Group, LLC's KZIA position evolved
Dauntless Investment Group, LLC first disclosed a stake in KZIA in Q2 2025 at 115,769 shares (US$726K). The position peaked in Q3 2026 at 866,223 shares, worth US$8.3M. Across 6 filings, Dauntless Investment Group, LLC increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 866,223 shares valued at US$8.3M — an increase of 512,015 shares quarter over quarter.. Notable position changes include a 7983100% increase in Q1 2026 (shares rose 89% over the following quarter), a 344% increase in Q2 2026 (shares fell 32% over the following quarter), a 145% increase in Q3 2026 (shares fell 42% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 115.77K | $725.87K | New |
| Q3 2025 | 118.14K | $851.78K | Add |
| Q4 2025 | 1 | $7 | Reduce |
| Q1 2026 | 79.83K | $593.95K | Add |
| Q2 2026 | 354.21K | $4.99M | Add |
| Q3 2026 | 866.22K | $8.31M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KZIA and 13F data
KZIA (KAZIA THERAPEUTICS LTD) is a Health Care company. 60 other funds we track also report a position in KZIA — the largest reported positions include Bleichroeder LP (US$4.7M), Stonepine Capital Management, LLC (US$3.6M), Boxer Capital Management, LLC (US$3.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KZIA
- Bleichroeder LP 490.41K sh · $4.71M · Q3 2026
- Stonepine Capital Management, LLC 377.43K sh · $3.62M · Q3 2026
- Boxer Capital Management, LLC 371.50K sh · $3.56M · Q3 2026
- Lynx1 Capital Management LP 225.80K sh · $2.17M · Q3 2026
- Knoll Capital Management, LLC 129.00K sh · $1.24M · Q3 2026
- Kalehua Capital Management LLC 56.01K sh · $537.45K · Q3 2026
- COOPERMAN LEON G 50.00K sh · $479.75K · Q3 2026
- ACT Capital Partners, L.P. 35.00K sh · $335.82K · Q3 2026
More on Dauntless Investment Group, LLC
FAQ
How long has Dauntless Investment Group, LLC held KZIA?
Dauntless Investment Group, LLC has disclosed KZIA holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Dauntless Investment Group, LLC's current position in KZIA?
As of Q3 2026, Dauntless Investment Group, LLC holds 866.22K shares of KZIA (KAZIA THERAPEUTICS LTD), valued at $8.31M, representing 8.44% of its reported portfolio and ranking #4.
Has Dauntless Investment Group, LLC been buying or selling KZIA?
In the latest 13F filing (Q3 2026), Dauntless Investment Group, LLC increased its position in KZIA. The position peaked in Q3 2026 at 866.22K shares.
Which other funds hold KZIA?
Other major institutional holders of KZIA include Bleichroeder LP, Stonepine Capital Management, LLC, Boxer Capital Management, LLC, among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.